user

Verification and Comparison of Chromogenic Factor VIII Activity Assays in Patients With Hemophilia Treated With and Without Emicizumab

被引：0
|
作者：
Lee, Min Young [1 ,2 ]
Lee, Woo In [1 ,2 ]
Kang, So Young [1 ,2 ]
Kim, Myeong Hee [1 ,2 ]
Park, Young Shil [2 ,3 ]
机构：
[1] Kyung Hee Univ, Sch Med, Dept Lab Med, 892 Dongnam Ro, Seoul 05278, South Korea
[2] Kyung Hee Univ Hosp Gangdong, 892 Dongnam Ro, Seoul 05278, South Korea
[3] Kyung Hee Univ, Sch Med, Dept Pediat, Seoul, South Korea
来源：
ANNALS OF LABORATORY MEDICINE | 2023年 / 43卷 / 01期
关键词：
D O I：
10.3343/alm.2023.43.1.96
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：96 / 99
页数：4
相关论文
共 50 条
  • [1] VERIFICATION AND COMPARISON OF CHROMOGENIC FVIII ASSAY IN HEMOPHILIA PATIENTS WITH/WITHOUT EMICIZUMAB
    Lee, MinYoung
    Lee, Woo In
    Kang, So Young
    Kim, Myeong Hee
    Park, Young Shil
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 : 102 - 103
  • [2] FACTOR VIII LEVEL COMPARISON IN PATIENTS WITH SEVERE HEMOPHILIA A ON EMICIZUMAB WITH INHIBITORS WITH ONE STAGE, BOVINE AND HUMAN CHROMOGENIC ASSAYS AND THE FACTOR VIII EQUIVALENCY OF EMICIZUMAB USING IN VIVO GLOBAL HEMOSTASIS ASSAYS
    Kizilocak, Hande
    Marquez-Casas, Elizabeth
    Brown, Joshua
    Malvar, Jemily
    Young, Guy
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E58 - E58
  • [3] Factor VIII Level Comparison in Patients with Severe Hemophilia a on Emicizumab with Inhibitors with One Stage, Bovine and Human Chromogenic Assays and the Factor VIII Equivalency of Emicizumab Using In Vivo Global Hemostasis Assays
    Kizilocak, Hande
    Marquez-Casas, Elizabeth
    Brown, Joshua
    Malvar, Jemily
    Young, Guy
    [J]. BLOOD, 2021, 138
  • [4] USE OF CHROMOGENIC FACTOR VIII ACTIVITY DETERMINATION IN HEMOPHILIA A PLASMA OF PATIENTS UNDER EMICIZUMAB TREATMENT
    Unterberger, M.
    Wagner, L.
    Binder, N. B.
    [J]. HAEMATOLOGICA, 2019, 104 : 17 - 17
  • [5] Factor VIII assays in treated hemophilia A patients
    Lasne, Dominique
    Pouplard, Claire
    Nougier, Christophe
    Eschwege, Valerie
    Duchez, Veronique Le Cam
    Proulle, Valerie
    Smahi, Motalib
    Harzallah, Ines
    Voisin, Sophie
    Toulon, Pierre
    Sobas, Frederic
    Galinat, Hubert
    Flaujac, Claire
    Ternisien, Catherine
    Jeanpierre, Emmanuelle
    [J]. HEMATOLOGIE, 2019, 25 (06): : 298 - 315
  • [6] Factor VIII assays in treated hemophilia A patients
    Lasne, Dominique
    Pouplard, Claire
    Nougier, Christophe
    Eschwege, Valerie
    Duchez, Veronique Le Cam
    Proulle, Valerie
    Smahi, Motalib
    Harzallah, Ines
    Voisin, Sophie
    Toulon, Pierre
    Sobas, Frederic
    Galinat, Hubert
    Flaujac, Claire
    Ternisien, Catherine
    Jeanpierre, Emmanuelle
    Gelas, Martine Alhenc
    Biron, Christine
    Blanc-Jouvan, Florence
    Bourgerette, Evelyne
    Bulabois, Benedicte
    Comio, Emilie
    Donnard, Magali
    Duchemin, Jerome
    Faure, Anne-Camille
    Grand, Francois
    Grunebaum, Lelia
    Guicheteau, Maryse
    Hezard, Nathalie
    Hurtaud, Marie-Francoise
    Gac, Fabienne Nedelec
    De Maistre, Emmanuel
    Marlu, Raphael
    Mourey, Guillaume
    Munier, Perrine
    Pineau-Vincent, Fabienne
    Raffenot, Didier
    Repesse, Yohan
    Ryman, Anne
    Sattler, Laurent
    Sauguet, Pauline
    Serre-Sapin, Anne-Francoise
    Stepanian, Alain
    Szymezak, Jean
    Tuffigo, Marie
    Voyer, Annelise
    [J]. ANNALES DE BIOLOGIE CLINIQUE, 2019, 77 (01) : 53 - 65
  • [7] Validation of the chromogenic Bethesda assay for factor VIII inhibitors in hemophilia a patients receiving Emicizumab
    Miller, Connie H.
    Boylan, Brian
    Payne, Amanda B.
    Driggers, Jennifer
    Bean, Christopher J.
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (02) : E84 - E86
  • [8] Emicizumab for hemophilia A with factor VIII inhibitors
    Young, Guy
    Callaghan, Michael
    Dunn, Amy
    Kruse-Jarres, Rebecca
    Pipe, Steven
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (11) : 835 - 846
  • [9] Regression Analysis to Estimate the Factor VIII Activity of Patients with Hemophilia A Without Inhibitor who Received Emicizumab Therapy
    Hatayama, Yuki
    Motokura, Toru
    Hosoda, Yuzuru
    Suzuki, Sayaka
    Namba, Hiroya
    Kato, Konami
    Kojima, Nao
    Horie, Takuya
    Iwamoto, Takuya
    Yamashita, Noriko
    Ichikawa, Hitomi
    Fukuda, Tetsuya
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [10] Regression Analysis to Estimate the Factor VIII Activity of Patients with Hemophilia A Without Inhibitor who Received Emicizumab Therapy
    Hatayama, Yuki
    Motokura, Toru
    Hosoda, Yuzuru
    Suzuki, Sayaka
    Namba, Hiroya
    Kato, Konami
    Kojima, Nao
    Horie, Takuya
    Iwamoto, Takuya
    Yamashita, Noriko
    Ichikawa, Hitomi
    Fukuda, Tetsuya
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
12345